Provided by Tiger Trade Technology Pte. Ltd.

iBio

1.00
-0.0500-4.76%
Volume:1.51M
Turnover:1.49M
Market Cap:64.31M
PE:-3.15
High:1.06
Open:1.05
Low:0.9700
Close:1.05
52wk High:3.82
52wk Low:0.7811
Shares:64.31M
Float Shares:52.11M
Volume Ratio:2.31
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3175
EPS(LYR):-0.3175
ROE:-65.70%
ROA:-30.80%
PB:0.75
PE(LYR):-3.15

Loading ...

Analyst Maintains Buy on IBIO, Keeps Price Target Unchanged at $7 on Promising IBIO-610 Obesity Therapy Data

TIPRANKS
·
Oct 02

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

HC Wainwright Initiates iBio With Buy Rating, $7 Price Target

MT Newswires Live
·
Sep 17

iBio Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 17

Ibio, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $7

THOMSON REUTERS
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

iBio Highlights Breakthrough Antibody Strategy for Obesity

TIPRANKS
·
Sep 15

iBio Announces Annual Shareholder Meeting

Reuters
·
Sep 05

iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Analyst Warns of Significant Clinical and Regulatory Risks Facing Ibio Inc’s Drug Pipeline

TIPRANKS
·
Aug 31

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 29

iBio Advances IBIO-600 into Phase 1 Multiple-Ascending-Dose Trial Stage After Completing Single-Ascending-Dose Dosing

Reuters
·
Aug 28

iBio FY26 Net Loss Widens to $33.04 Million; Revenue Drops to $100,000

Reuters
·
Aug 28

Ibio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 28

Press Release: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 28

iBio Announces 2026 Annual Shareholder Meeting

Reuters
·
Aug 20

iBio appoints Molly Carr as chief medical officer

TIPRANKS
·
Aug 04

iBio Files Form 3 for Chief Medical Officer Molly Carr

Reuters
·
Aug 04

iBio Names Endocrinologist Molly Carr as Chief Medical Officer

Reuters
·
Aug 04

Ibio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

THOMSON REUTERS
·
Aug 04